Updated for 2022
Please note: The 2022 grant application process is by invitation only.
- Applications received after 11:59 p.m. Central Standard Time November 1, 2021 will not be considered.
- A team of research experts led by Dr. Michael Meyers will review the proposals and make recommendations to the trust. Awards will be announced during the month of May 2022. Special consideration will be given in the area of career development.
- Applications will be accepted for a broad range of melanoma research projects involving basic science, clinical trials, etc.
- An adequate discussion of biostatistics is required, including but not limited to specification of numbers of cell lines, laboratory animals, or patients to be treated in the studies.
- Plans for adjustment for multiple looks should be presented, particularly in regards to clinical endpoints and evaluation of multiple biomarkers.
- Applications from non-profit organizations under the U. S. Internal Revenue Code Section 501(c) (3) are eligible for consideration. If a grant recipient is a foreign entity not under the U. S. Internal Revenue Code, an Affidavit related to non-profit status must be completed prior to payment of grant funds. The Affidavit is available on request.
- The funding is considered a research grant, and The Harry J. Lloyd Charitable Trust funds cannot be applied to institutional overhead, indirect costs, or other organizational levies.
- Applications should be in narrative form and can be no longer than five typewritten pages in length. Additional supportive attachments are acceptable, but they must be pertinent.
- An investigator form is required for each named investigator.
- Biographical sketches (NIH format or short form) are required for all research personnel.
- Include a justified budget for the proposed project.
- Please submit your proposal and all attachments online using this site.
- Fill out the appropriate award application sheet.
- Include a letter of recommendation from a member of the Lloyd Trust advisory committee.
- Because the Lloyd Trust board of trustees believes that all of life is infused with great value, the following ethical guidelines apply to all grants.
- Recipients will use animals in research only when non-animal options are not available and when the use of animals helps answer significant scientific questions. Recipients will make every effort to minimize distress and pain experienced by the animals.
- Recipients will not use embryonic or fetal cell culture tissues systems in any research funded by the Lloyd Trust.
- The use of transgenic animal models in which human genes are inserted into the germ line requires advanced approval by the trust.
- Copies of the Conditions of Award agreement are available upon request.
- Grant recipients will be asked to submit a brief written report at the end of the funding period.
- Do not include hyperlinks within the text or documents that are submitted.